首页|普米克令舒配合有氧运动对支气管哮喘康复效果的影响研究

普米克令舒配合有氧运动对支气管哮喘康复效果的影响研究

扫码查看
目的 观察普米克令舒配合有氧运动对改善支气管哮喘患者康复效果的影响。方法 本文为前瞻性研究,选择郑州四六〇医院 2020 年 10 月至 2023 年 3 月期间收治的 100 例支气管哮喘患者为研究对象采用计算机随机数字表法将其分为常规组和联合组,各 50 例。常规组在常规药物治疗基础上配合有氧运动,联合组在常规药物治疗基础上加用普米克令舒配合有氧运动,比较两组的症状缓解时间,治疗前后的炎症反应、肺功能改善情况、哮喘控制测试(ACT)评分改善情况及治疗安全性。结果 联合组的咳嗽消失时间、呼吸困难缓解时间、肺部啰音消失时间、喘息消失时间及住院时间分别为(6。44±2。12)d、(1。82±0。46)d、(3。36±0。77)d、(2。51±0。46)d、(14。49±3。46)d,均低于常规组[(9。77±3。42)d、(2。35±0。26)d、(4。49±1。26)d、(3。23±0。46)d、(17。72±5。36)d];联合组治疗后的Toll样受体(TLR)2、TLR4 表达量分别为(1。35±0。41)、(0。85±0。21),均低于常规组[(1。77±0。45)、(1。18±0。36)];联合组治疗 30d后的第一秒用力呼气容积百分比(FEV1)、用力肺活量(FVC)、每分钟最大通气量(MVV)分别为(58。65±10。27)%、(2。75±0。36)L、(68。82±10。31)L/min,均高于常规组[(52。11±10。44)%、(2。21±0。25)L、(62。44±10。63)L/min];联合组治疗 7d后、14d后、30d后的ACT评分分别为(17。23±4。49)分、(21。77±5。42)分、(26。33±5。49)分,均高于常规组[(14。33±3。45)分、(18。28±5。16)分、(23。19±5。25)分];联合组药物不良反应发生率 8。00%(4/50)低于 24。00%(12/50),差异具有统计学意义(P<0。05)。结论 普米克令舒配合有氧运动能加快支气管哮喘患者的康复进程,对改善患者气道炎症、肺功能,控制哮喘症状、增强康复效果,提升治疗安全性均有积极意义。
Study on the Effect of Pulmicort Respules Combined with Aerobic Exercise on the Rehabilitation of Bronchial Asthma
Objective Observing the effect of combination of pulmicort respules and aerobic exercise on improving the rehabilitation effect of patients with bronchial asthma.Methods This article was a prospective study,selecting 100 patients with bronchial asthma admitted to Zhengzhou 460 Hospital from October 2020 to March 2023 as the research subjects.They were randomLy divided into a conventional group and a combination group using a computer random number table method,with 50 cases in each group.The conventional group was treated with conventional medication combined with aerobic exercise,while the combination group was treated with adjuvant therapy of pulmicort respules on based of conventional group.The symptom relief time,inflammation response,improvement of lung function before and after treatment,improvement of asthma control test(ACT)score,and treatment safety were compared between the two groups.Results The cough disappearance time,dyspnea relief time,lung rale disappearance time,wheezing disappearance time,and hospitalization time of the combination group were(6.44±2.12)d,(1.82±0.46)d,(3.36±0.77)d,(2.51±0.46)d,and(14.49±3.46)d,lower than the conventional group[(9.77±3.42)d,(2.35±0.26)d,(4.49±1.26)d,(3.23±0.46)d,and(17.72±5.36)d];under different treatment regimens,the expression levels of Toll like receptor 2(TLR2)and TLR4 in the combination group after treatment were(1.35±0.41)and(0.85±0.21),lower than the conventional group[(1.77±0.45)and(1.18±0.36)];the first second forced expiratory volume percentage(FEV1),forced vital capacity(FVC),and maximum ventilation volume per minute(MVV)of the combination group after 30 days of treatment were(58.65±10.27)%,(2.75±0.36)L,and(68.82±10.31)L/min,higher than the conventional group[(52.11±10.44)%,(2.21±0.25)L,and(62.44±10.63)L/min];the ACT scores of the combined group after 7 days,14 days,and 30 days of treatment were(17.23±4.49)points,(21.77±5.42)points,and(26.33±5.49)points,higher than the conventional group[(14.33±3.45)points,(18.28±5.16)points,and(23.19±5.25)points];the incidence of adverse reactions in the combination group was 8.00%(4/50),lower than 24.00%(12/50)(P<0.05).Conclusion Pulmicort respules combined with aerobic exercise can accelerate the rehabilitation process of patients with bronchial asthma,improve airway inflammation and lung function,control asthma symptoms,enhance rehabilitation effectiveness,and enhance treatment safety,all of which have positive significance.

Bronchial asthmaPulmicort respulesAirway inflammationLung functionAsthma control test

潘文文、王楠

展开 >

郑州四六〇医院,河南 郑州 450000

支气管哮喘 普米克令舒 气道炎症 肺功能 哮喘控制测试

河南省医学科技攻关项目

LHGJ202001172

2024

药品评价
江西省药学会

药品评价

影响因子:0.672
ISSN:1672-2809
年,卷(期):2024.21(1)
  • 20